Kevin Caliendo
Stock Analyst at UBS
(4.56)
# 202
Out of 4,827 analysts
178
Total ratings
70.24%
Success rate
12.05%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Buy | $14 → $15 | $9.05 | +65.75% | 3 | May 9, 2025 | |
| AMWL American Well | Maintains: Neutral | $12 → $9 | $6.79 | +32.55% | 3 | May 8, 2025 | |
| NVST Envista Holdings | Maintains: Neutral | $21 → $18 | $17.59 | +2.33% | 3 | May 5, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $16 → $17 | $15.12 | +12.47% | 7 | May 2, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $160 → $170 | $148.22 | +14.69% | 17 | May 2, 2025 | |
| CVS CVS Health | Maintains: Neutral | $67 → $71 | $66.97 | +6.02% | 7 | May 2, 2025 | |
| MCK McKesson | Maintains: Buy | $708 → $805 | $693.46 | +16.08% | 14 | Apr 29, 2025 | |
| COR Cencora | Maintains: Buy | $298 → $335 | $283.00 | +18.37% | 2 | Apr 29, 2025 | |
| ALGN Align Technology | Maintains: Neutral | $240 → $215 | $181.88 | +18.21% | 18 | Apr 24, 2025 | |
| HSIC Henry Schein | Maintains: Neutral | $83 → $80 | $68.64 | +16.55% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $13 | $7.01 | +85.45% | 5 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $330 → $305 | $322.20 | -5.34% | 3 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $333.46 | +16.96% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $166 → $170 | $176.96 | -3.93% | 13 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $293 → $286 | $245.73 | +16.39% | 2 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $27 | $15.82 | +70.67% | 9 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $11.22 | -10.87% | 14 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $680 → $650 | $380.73 | +70.72% | 11 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $249.53 | +0.19% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $7.5 | $5.73 | +30.89% | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $8.5 | $4.32 | +96.76% | 3 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $62.79 | +25.82% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $26 | $23.07 | +12.70% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $404.58 | +42.12% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $154.22 | +16.72% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $7.11 | +912.66% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $16.93 | -35.03% | 4 | May 4, 2021 |
Evolent Health
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $9.05
Upside: +65.75%
American Well
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $6.79
Upside: +32.55%
Envista Holdings
May 5, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $17.59
Upside: +2.33%
Alignment Healthcare
May 2, 2025
Maintains: Neutral
Price Target: $16 → $17
Current: $15.12
Upside: +12.47%
Cardinal Health
May 2, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $148.22
Upside: +14.69%
CVS Health
May 2, 2025
Maintains: Neutral
Price Target: $67 → $71
Current: $66.97
Upside: +6.02%
McKesson
Apr 29, 2025
Maintains: Buy
Price Target: $708 → $805
Current: $693.46
Upside: +16.08%
Cencora
Apr 29, 2025
Maintains: Buy
Price Target: $298 → $335
Current: $283.00
Upside: +18.37%
Align Technology
Apr 24, 2025
Maintains: Neutral
Price Target: $240 → $215
Current: $181.88
Upside: +18.21%
Henry Schein
Feb 26, 2025
Maintains: Neutral
Price Target: $83 → $80
Current: $68.64
Upside: +16.55%
Feb 13, 2025
Maintains: Buy
Price Target: $25 → $13
Current: $7.01
Upside: +85.45%
Feb 7, 2025
Maintains: Neutral
Price Target: $330 → $305
Current: $322.20
Upside: -5.34%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $333.46
Upside: +16.96%
Feb 3, 2025
Maintains: Neutral
Price Target: $166 → $170
Current: $176.96
Upside: -3.93%
Jan 28, 2025
Maintains: Buy
Price Target: $293 → $286
Current: $245.73
Upside: +16.39%
Dec 3, 2024
Maintains: Buy
Price Target: $35 → $27
Current: $15.82
Upside: +70.67%
Oct 17, 2024
Maintains: Neutral
Price Target: $9 → $10
Current: $11.22
Upside: -10.87%
Oct 16, 2024
Maintains: Buy
Price Target: $680 → $650
Current: $380.73
Upside: +70.72%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $249.53
Upside: +0.19%
Aug 15, 2024
Maintains: Neutral
Price Target: $9 → $7.5
Current: $5.73
Upside: +30.89%
Aug 9, 2024
Maintains: Neutral
Price Target: $9 → $8.5
Current: $4.32
Upside: +96.76%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $62.79
Upside: +25.82%
Aug 23, 2023
Maintains: Neutral
Price Target: $29 → $26
Current: $23.07
Upside: +12.70%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $404.58
Upside: +42.12%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $154.22
Upside: +16.72%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $7.11
Upside: +912.66%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $16.93
Upside: -35.03%